SAN DIEGO, October 26, 2023 – ResMed Inc. (NYSE: RMD, ASX: RMD) announced results for its
quarter ended September 30, 2023.
First Quarter 2024 Highlights
All comparisons are to the prior year period
• Revenue increased by 16% to $1.1 billion; up 15% on a constant currency basis
• Gross margin contracted 250 bps to 54.4%; non-GAAP gross margin contracted 160 bps to 56.0%
• Income from operations increased 5%; non-GAAP operating profit up 10%
• Operating cash flow of $286.3 million
• Diluted earnings per share of $1.49; non-GAAP diluted earnings per share of $1.64
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$38.60 |
Change
0.080(0.21%) |
Mkt cap ! $22.46B | |||
| Open | High | Low | Value | Volume |
| $38.59 | $38.75 | $38.38 | $15.79M | 409.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 898 | $38.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $38.63 | 2182 | 2 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| RMD (ASX) Chart |